臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"chiun hsu"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 36-85 / 356 (共8頁)
1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-08-19T00:21:04Z	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	Liou J.-Y.; Shyue S.-K.; Chang C.-C.; Golubovskaya V.M.; Shen T.-L.; Shen Y.-C.; CHIUN HSU; Kuo C.-C.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.
臺大學術典藏	2022-08-19T00:21:04Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	CHIUN HSU; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:04Z	Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma	Jan Y.-J.; Ko B.-S.; CHIUN HSU; Chang T.-C.; Chen S.-C.; Wang J.; Liou J.-Y.
臺大學術典藏	2022-08-19T00:21:04Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	CHIUN HSU; Shen Y.-C.; Cheng A.L.
臺大學術典藏	2022-08-19T00:21:03Z	Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: Experts'opinion	Chen P.-J.; Furuse J.; Han K.-H.; CHIUN HSU; Lim H.-Y.; Moon H.; Qin S.; Ye S.-L.; Yeoh E.-M.; Yeo W.
臺大學術典藏	2022-08-19T00:21:03Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Cheng A.-L.; Ding Y.-H.; CHIUN HSU; Shao Y.-Y.; Chen P.-J.; Lin Z.-Z.; Shen Y.-C.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:21:02Z	Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma	Whang-Peng J.; Cheng A.-L.; CHIUN HSU; Chen C.-M.
臺大學術典藏	2022-08-19T00:21:02Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Cheng A.-L.; Lin C.-H.; Chang K.-J.; Kuo W.-H.; CHIUN HSU; Lee W.-C.; Liau J.-Y.; Huang C.-S.; Lu Y.-S.; Shao Y.-Y.; Kuo K.-T.; Hu F.-C.
臺大學術典藏	2022-08-19T00:21:01Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; CHIUN HSU; Lin Z.-Z.; Shao Y.-Y.
臺大學術典藏	2022-08-19T00:21:00Z	Overexpression of 14-3-3�` predicts tumour metastasis and poor survival in hepatocellular carcinoma	Liou J.-Y.; Ko B.-S.; Chang T.-C.; CHIUN HSU; Chen Y.-C.; Shen T.-L.; Chen S.-C.; Wang J.; Wu K.K.; Jan Y.-J.
臺大學術典藏	2022-08-19T00:21:00Z	Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil	Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.; Chen B.-B.; Hsu C.-H.; Hu F.-C.; CHIUN HSU; Yu C.-W.; Shen Y.-C.; Hsu C.-Y.
臺大學術典藏	2022-08-19T00:20:59Z	Increased expression of 14-3-3�] promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma	Shen T.-L.; Lee Y.-M.; Chen P.-F.; Wang J.; Shyue S.-K.; Liou J.-Y.; CHIUN HSU; Liang S.-M.; Hung Y.-L.; Chen S.-C.; Jan Y.-J.; Ko B.-S.; Liu T.-A.
臺大學術典藏	2022-08-19T00:20:59Z	Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era	Lu Y.S.; Cheng A.L.; Kuo W.H.; Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:58Z	Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; CHIUN HSU; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:58Z	Antiangiogenic strategies for the treatment of hepatocellular carcinoma	CHIUN HSU; Shen Y.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:57Z	Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy	Yang C.-H.; Hong R.-L.; Hsu C.-H.; Chengb A.-L.; Chang D.-Y.; Hu F.-C.; Shao Y.-Y.; CHIUN HSU; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:20:57Z	Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study	Cheng A.-L.; Meng R.; Chao Y.; Hsieh T.-Y.; Huang W.-T.; Hwang W.-S.; Yu C.-W.; Hsieh R.-K.; Huo T.-I.; Yang T.-S.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:57Z	A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: A novel approach by using meta-regression	Shen Y.-C.; CHIUN HSU; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:56Z	Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression	Yeh K.-H.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Shen Y.-C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:55Z	Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy	Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; CHIUN HSU; Lu Y.-S.; Cheng A.-L.; Lin C.-H.; Kuo Y.-H.
臺大學術典藏	2022-08-19T00:20:55Z	Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems	Shen Y.-C.; Hsu C.-H.; Cheng A.-L.; CHIUN HSU; Lin Z.-Z.; Lu L.-C.; Shao Y.-Y.
臺大學術典藏	2022-08-19T00:20:55Z	Comparative microRNA detection from precursor-microRNA-transfected hepatocellular carcinoma cells by capillary electrophoresis with dual-color laser-induced fluorescence	Yang T.-H.; Ou D.-L.; CHIUN HSU; Huang S.-H.; Chang P.-L.
臺大學術典藏	2022-08-19T00:20:55Z	erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)	CHIUN HSU; Shen Y.-C.; Cheng C.-C.; Cheng A.-L.; Hu F.-C.; Yeh K.-H.
臺大學術典藏	2022-08-19T00:20:54Z	The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines	Cheng A.-L.; Lu Y.-S.; Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; CHIUN HSU; Lin M.-H.; Huang C.-S.
臺大學術典藏	2022-08-19T00:20:54Z	Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients	Yeh K.H.; Hu F.C.; Chang S.Y.; Kao H.F.; Chen Y.C.; Chien S.F.; Chen I.C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:53Z	Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma	Liu S.-H.; Cheng A.-L.; Lin C.-Y.; Chang C.-Y.; Lin K.-L.; CHIUN HSU; Ou D.-L.; Shen Y.-C.
臺大學術典藏	2022-08-19T00:20:53Z	Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway	Liou J.-Y.; CHIUN HSU; Cheng A.-L.; Lin L.-I.; Lee B.-S.; Chang Y.-C.; Ou D.-L.
臺大學術典藏	2022-08-19T00:20:53Z	14-3-3�` Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma	Wu Y.-M.; Liou J.-Y.; Wang J.; CHIUN HSU; Chen S.-C.; Liang S.-M.; Ko B.-S.; Jan Y.-J.; Liu T.-A.
臺大學術典藏	2022-08-19T00:20:52Z	Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group	Kim W.S.; Kwong Y.-L.; Suh C.; Lim S.T.; Cheng A.-L.; Chng W.-J.; Lee J.; Intragumtornchai T.; Kim S.J.; CHIUN HSU; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.
臺大學術典藏	2022-08-19T00:20:51Z	Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies	Liu K.-L.; Liang P.-C.; Shih T.T.-F.; Chen C.-H.; CHIUN HSU; Wu C.-H.; Shih I.-L.; Chen B.-B.
臺大學術典藏	2022-08-19T00:20:51Z	Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size	Lai M.-S.; Yang J.C.-H.; Cheng A.-L.; Hsu C.-H.; Kuo R.N.-C.; Yeh Y.-C.; Shao Y.-Y.; CHIUN HSU; Shau W.-Y.; Lin Z.-Z.
臺大學術典藏	2022-08-19T00:20:50Z	Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan	Chang Y.-T.; Chang M.-C.; Huang K.-W.; Tung C.-C.; CHIUN HSU; Wong J.-M.
臺大學術典藏	2022-08-19T00:20:50Z	Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study	Cheng A.-L.; Chen P.-J.; Liu T.-W.; Chang C.-S.; Tien H.-F.; CHIUN HSU; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J.
臺大學術典藏	2022-08-19T00:20:49Z	Reply	CHIUN HSU; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:20:48Z	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity	Cheng A.-L.; Wang H.-P.; Tsai H.-J.; Wu M.-S.; Tzeng Y.-S.; Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:48Z	Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma	Chang M.-C.; Chen C.-H.; Liang J.-D.; Tien Y.-W.; CHIUN HSU; Wong J.-M.; Chang Y.-T.
臺大學術典藏	2022-08-19T00:20:47Z	A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma	Tak W.Y.; Yen C.-J.; Jeffers M.; Krissel H.; Kappeler C.; Rajagopalan P.; Hsieh W.-S.; Tay M.H.; Yeo W.; Park J.-W.; Poon R.T.P.; Rau K.-M.; CHIUN HSU; Yoon J.-H.; Lin C.-Y.; Choi H.J.; Heo J.; Lim H.Y.
臺大學術典藏	2022-08-19T00:20:46Z	H3K9 histone methyltransferase, KMT1E/SETDB1, Cooperates with the SMAD2/3 pathway to suppress lung cancer metastasis	Wu P.-C.; Lu J.-W.; Yang J.-Y.; Lin I.-H.; Ou D.-L.; Lin Y.-H.; Chou K.-H.; Huang W.-F.; Wang W.-P.; Huang Y.-L.; CHIUN HSU; Lin L.-I.; Lin Y.-M.; James Shen C.-K.; Tzeng T.-Y.
臺大學術典藏	2022-08-19T00:20:46Z	Gemcitabine plus cisplatin for advanced biliary tract cancer: A systematic review	Lim H.Y.; Kim J.S.; Orlando M.; Chen L.-T.; Chen J.-S.; CHIUN HSU; Oh D.-Y.; Park J.O.
臺大學術典藏	2022-08-19T00:20:45Z	The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia	Yang J.C.H.; Lai M.-S.; Cheng A.-L.; Cheng W.-F.; CHIUN HSU; Shao Y.-Y.; Yang Y.-Y.; Lai C.-L.; Shau W.-Y.; Kuo R.; Lin Z.-Z.; Kuo H.-Y.
臺大學術典藏	2022-08-19T00:20:45Z	A decade of changes in preferences for life-sustaining treatments among terminally ill patients with cancer	Chiang M.-C.; Liu L.N.; Sung Y.-C.; Hsieh C.-I.; Chang S.-Y.; Chang Y.-H.; Chang C.-S.; CHIUN HSU; Wen F.-H.; Liu T.-W.; Tang S.T.
臺大學術典藏	2022-08-19T00:20:45Z	Consensus development from the 5th asia-pacific primary liver cancer expert meeting (APPLE 2014)	Cheng A.-L.; Han K.-H.; Jia J.-D.; Seong J.; CHIUN HSU; Chen B.-B.; Chen C.-H.; Ho M.-C.; Cheng J.C.-H.; Kokudo N.; Murakami T.; Yeo W.
臺大學術典藏	2022-08-19T00:20:44Z	Cough with bile	Liu K.-L.; CHIUN HSU; Chang C.-C.
臺大學術典藏	2022-08-19T00:20:44Z	Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy	Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; CHIUN HSU; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2022-08-19T00:20:43Z	Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression	Ou D.-L.; Cheng A.-L.; Shao Y.-Y.; Feng Z.-R.; Lin L.-I.; Cheng Y.-C.; CHIUN HSU
臺大學術典藏	2022-08-19T00:20:43Z	Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer	Chiang N.-J.; CHIUN HSU; Chen J.-S.; Tsou H.-H.; Shen Y.-Y.; Chao Y.; Chen M.-H.; Yeh T.-S.; Shan Y.-S.; Huang S.-F.; Chen L.-T.
臺大學術典藏	2022-08-19T00:20:42Z	Epithelioid Trophoblastic Tumor Around an Abdominal Cesarean Scar: A Pathologic and Molecular Genetic Analysis	Hsiue E.H.-C.; CHIUN HSU; Tseng L.-H.; Lu T.-P.; Kuo K.-T.
臺大學術典藏	2022-08-19T00:20:42Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	CHIUN HSU; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.; Guo J.-C.; Kuo T.-C.; Wu H.; Yang S.-H.
臺大學術典藏	2022-08-19T00:20:41Z	Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma	Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; CHIUN HSU; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2022-08-19T00:20:40Z	Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy	CHIUN HSU; Ou D.-L.; Cheng A.-L.; Chen C.-W.; Tan C.-T.; Lin Y.-Y.

顯示項目 36-85 / 356 (共8頁)
1 2 3 4 5 6 7 8 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52848203 線上人數 : 658 教育部委託研究計畫計畫執行:國立臺灣大學圖書館